Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

176.96 -1.49 (-0.83%)
Streaming Delayed Price Updated: 10:40 AM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telephone and Data Systems, Stem, Disney, and Charles River and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Charles River, Virtu, and Cutera and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
3 Long-term Healthcare Stocks to Add to Your Portfolio
These long-term healthcare stocks should benefit from the global surge in spending for life-improving pharmaceutical drugs, therapies, and medical devices. 
Via InvestorPlace
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids
From Charles River Laboratories International, Inc.
Via Business Wire
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories
From Bernstein Liebhard LLP
Via GlobeNewswire
Charles River Laboratories International Inc. (NYSE: CRL) Highlighted for Surprising Price Action
Via Investor Brand Network
Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy
From Charles River Laboratories International, Inc.
Via Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Charles River, Virtu, and Cutera and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration
From Charles River Laboratories International, Inc.
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
SHAREHOLDER DEADLINE REMINDER: Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against Charles River Laboratories International, Inc. (NYSE: CRL) Lead Plaintiff Deadline is July 18, 2023
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Charles River Laboratories International, Inc. (NYSE:CRL) Shareholder Notice: Lawsuit Alleges Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 06/07/2023 -- An investor, who purchased NYSE:CRL shares, filed a lawsuit against Charles River Laboratories International, Inc over alleged violations of Federal... 
Via SBWire
Charles River Laboratories to Present at William Blair and Jefferies Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stem, Disney, and Charles River and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
CRL LOSS ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – CRL
From The Rosen Law Firm PA
Via GlobeNewswire
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Charles River Laboratories International, Inc. (CRL) Investors and Encourages Investors to Contact the Firm Before July 18, 2023
From Kirby McInerney LLP
Via Business Wire
Charles River Laboratories International, Inc. (CRL) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Charles River Laboratories International, Inc. Class Action
From Robbins LLP
Via Business Wire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory
From Charles River Laboratories International, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Disney, Charles River, and TD and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.